SUPELCO INTRODUCES THE NEW ASCENTIS™ C8 HPLC COLUMN

Supelco, a division of Sigma-Aldrich Corporation (Nasdaq: SIAL), has introduced the new Ascentis™ C8 HPLC Column, which offers superior retention power and resolution even for difficult to separate analytes.

Complementing Ascentis’ family of HPLC columns, the C8 provides highly reproducible results and adds up to the range of stationary phase selectivities offered.

The Ascentis C8 HPLC Column can be run with high organic mobile phases, facilitating sample solubility as well as improving mass spectrometric detection. With the addition of the C8 to the C18 and RP Amide (an embedded polar group phase) columns, the Ascentis column now offers an excellent range of selectivities for method developers to choose. The Ascentis family has significant advantages, including improved stability for extremely long column life and ultra-low bleed for sensitive MS applications. The short and fast columns multiply productivity through elevated performance and higher reproducibility.

“The Ascentis HPLC column product line now comprises three different surface chemistries for achieving separations over a wide selectivity range,” says Klaus Herick, European Sales Development Manager at Supelco. “Customers can achieve optimal retention and selectivity by choosing the standard in RP-HPLC C18, the polar embedded RP-Amide that has a very different orthogonal selectivity compared to C18, or the new C8 phase that allows for superior retention of hydrophobic compounds.”

Supelco’s offering of HPLC products is part of the Company’s technological and value-driven products combined with services and support that provide complete analytical applications solutions.